Cubist Systematic Strategies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$30.6M Buy
40,100
+20,600
+106% +$15.3M 0.15% 151
2025
Q2
$15.2M Sell
19,500
-21,700
-53% -$16.9M 0.07% 401
2025
Q1
$34M Buy
41,200
+1,800
+5% +$1.5M 0.21% 74
2024
Q4
$30.4M Buy
39,400
+4,500
+13% +$3.73M 0.19% 85
2024
Q3
$30.9M Buy
34,900
+30,700
+731% +$27.6M 0.19% 92
2024
Q2
$3.8M Sell
4,200
-33,000
-89% -$26.4M 0.03% 940
2024
Q1
$28.9M Sell
37,200
-21,100
-36% -$15M 0.16% 89
2023
Q4
$34M Sell
58,300
-2,100
-3% -$1.23M 0.22% 45
2023
Q3
$32.4M Buy
60,400
+8,100
+15% +$4.17M 0.24% 45
2023
Q2
$24.5M Buy
52,300
+25,000
+92% +$10.5M 0.16% 90
2023
Q1
$9.38M Sell
27,300
-14,900
-35% -$5.03M 0.06% 492
2022
Q4
$15.4M Buy
42,200
+20,700
+96% +$7.34M 0.09% 266
2022
Q3
$6.95M Sell
21,500
-6,900
-24% -$2.19M 0.04% 769
2022
Q2
$9.21M Buy
+28,400
New +$8.52M 0.06% 498

Other funds holding LLY

Cubist Systematic Strategies's LLY Position: Q3 2025 in Review

Cubist Systematic Strategies increased its Eli Lilly (LLY) stake by 29% in Q3 2025, buying an estimated $2.33M and bringing the position to 13,889 shares worth $10.6M. The position accounts for 0.05% of the portfolio, ranked #530.

Cubist Systematic Strategies first reported a position in LLY in Q2 2014 and has held it in 42 quarters since. The position peaked at $40.6M in Q3 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Cubist Systematic Strategies held 13,889 shares of Eli Lilly worth $10.6M as of Q3 2025.
  • Cubist Systematic Strategies bought 3,128 Eli Lilly shares in Q3 2025, an estimated $2.33M.
  • Eli Lilly made up 0.05% of Cubist Systematic Strategies's portfolio in Q3 2025, its #530 holding.
  • Cubist Systematic Strategies first reported a position in Eli Lilly in Q2 2014 and has held it in 42 quarters since.
  • Cubist Systematic Strategies's Eli Lilly position peaked at $40.6M in Q3 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.